Policy Notices

• AHRQ Notice of Extension of PA-21-202
  (NOT-HS-21-011)
  Agency for Healthcare Research and Quality
  

• Publication of the Revised NIH Grants Policy Statement (Rev. April 2021) for Fiscal Year 2021
  (NOT-OD-21-107)
  National Institutes of Health
  

• Expanding Requirement for eRA Commons IDs to All Senior/Key Personnel
  (NOT-OD-21-109)
  National Institutes of Health
  Agency for Healthcare Research and Quality
  Food and Drug Administration
  

General Notices

• Notice of Pre-Application Technical Assistance Webinar for RFA-AT-21-006, "Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional)"
  (NOT-AT-21-010)
  National Center for Complementary and Integrative Health
  National Institute of Neurological Disorders and Stroke
  

• Pre-Application Webinar for the Clinical Proteomic Tumor Analysis Consortium (CPTAC): RFA-CA-21-023 (U24), RFA-CA-21-024 (U24), and RFA-CA-21-025 (U01)
  (NOT-CA-21-072)
  National Cancer Institute
  

• Continuation of Temporary Extension of Eligibility for the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) During the COVID-19 Pandemic
  (NOT-DE-21-003)
  National Institute of Dental and Craniofacial Research
  

• RESCINDED - NIDCR Policy on Applications for Investigator-Initiated Clinical Trials
  (NOT-DE-21-004)
  National Institute of Dental and Craniofacial Research
  

• Continuation of Temporary Extension of Applicant Eligibility in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)
  (NOT-GM-21-037)
  National Institute of General Medical Sciences
  

• Notice of Pre-Application Technical Assistance Webinar for RFA-MD-21-004, Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)
  (NOT-MD-21-018)
  National Institute on Minority Health and Health Disparities
  

• Notice of Intent to Reissue PAR-18-845 Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) and PAR-18-846 (R21 - Clinical Trial Not Allowed) as a Notice of Special Interest (NOSI)
  (NOT-OD-21-113)
  Office of Disease Prevention
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  

• Notice of Intent to Reissue PAR-18-847 Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01- Clinical Trial Optional) and PAR-18-848 (R21 - Clinical Trial Optional) as a Notice of Special Interest (NOSI)
  (NOT-OD-21-114)
  Office of Disease Prevention
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute on Minority Health and Health Disparities
  

• Notice of Pre-Application Webinar for Phase II of the RADxSM-UP Initiative
  (NOT-OD-21-115)
  National Institutes of Health
  

• Request for Information (RFI): Seeking Stakeholder Input on Enhancing Cancer Health Disparities Research
  (NOT-CA-21-066)
  National Cancer Institute
  

• Request for information (RFI) on enhancing the science for the Environmental influences on Child Health Outcomes (ECHO) program
  (NOT-OD-21-108)
  National Institutes of Health
  National Institute of Allergy and Infectious Diseases
  

Notice of Changes to Funding Opportunities

• Notice of NIAMS Participation in PAR-19-343, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)"
  (NOT-AR-21-020)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Change to NOT-OD-21-087, Notice of Special Interest (NOSI): Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being
  (NOT-CA-21-065)
  National Cancer Institute
  

• Notice of Change to PAR-20-238, "Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)"
  (NOT-DA-21-037)
  National Institute on Drug Abuse
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  National Library of Medicine
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  

• Notice of Change to PAR-20-214, "Research to Improve Native American Health (R21 Clinical Trials Optional)"
  (NOT-DA-21-038)
  National Institute on Drug Abuse
  National Institute on Minority Health and Health Disparities
  

• Notice of Requirement for Submission of Current and Pending Support Information for the PD(s)/PI(s) of PAR-20-115 Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase 3 - Transitional Centers (P30)"
  (NOT-GM-21-038)
  National Institute of General Medical Sciences
  

• Notice of Requirement for Submission of Current and Pending Support Information in PAR-19-313 Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional)
  (NOT-GM-21-039)
  National Institute of General Medical Sciences
  

• Notice of Requirement for Submission of Current and Pending Support Information in PAR-19-312 Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 Clinical Trial Optional)
  (NOT-GM-21-045)
  National Institute of General Medical Sciences
  

• Notice of Additional Information for PAR-20-101, Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed)
  (NOT-HD-21-028)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Early Termination of PAR-21-162, Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
  (NOT-NS-21-056)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Early Termination of PAR-21-152, NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed).
  (NOT-NS-21-060)
  National Institute of Neurological Disorders and Stroke
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01)
  (NOT-AA-21-016)
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute of Mental Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24)
  (NOT-AA-21-017)
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute of Mental Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24)
  (NOT-AA-21-018)
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute of Mental Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed)
  (NOT-CA-21-060)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions (TBEL) (U24 Clinical Trial Not Allowed)
  (NOT-CA-21-061)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)
  (NOT-CA-21-068)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating Center for Canine Cancer Immunotherapy Network (K9CIN; U24 Clinical Trial Not Allowed)
  (NOT-CA-21-069)
  National Cancer Institute
  

Notices of Special Interest

• RESCINDED - Notice of Special Interest (NOSI): Availability of Funds to defray Childcare Costs for NCI, NHGRI, NIA, NIDCR, NIDDK, and NIH Blueprint Predoctoral to Postdoctoral Fellow Transition Programs F99 Awardees
  (NOT-CA-21-053)
  National Cancer Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Neurological Disorders and Stroke
  

• Notice of Special Interest (NOSI): Administrative Supplements to Stimulate and Strengthen Global Cancer Survivorship Research
  (NOT-CA-21-058)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence
  (NOT-DA-21-012)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Administrative Supplements to Promote Diversity for NINDS Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) Awardees
  (NOT-NS-21-047)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for Administrative Supplements to Support Career Enhancement Related to Clinical Research on Pain (Admin Supp Clinical Trial Not Allowed)
  (NOT-NS-21-048)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Nursing Research
  

Funding Opportunities

• NICHD Small Research Grant Program (R03 Clinical Trial Required)
  (PA-21-221)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
  (PA-21-231)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NIH Countermeasures Against Chemical Threats (CounterACT) Early-stage Investigator Research Award (R21 Clinical Trial Not Allowed)
  (PAR-21-209)
  National Institute of Neurological Disorders and Stroke
  National Eye Institute
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
  (PAR-21-233)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): August 10, 2021, February 9, 2022, August 9, 2022, February 9, 2023, August 9, 2023, February 9, 2024
  
  

• NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)
  (PAR-21-234)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 12, 2021.
  
  

• Centers for HIV Structural Biology (U54 Clinical Trial Not Allowed)
  (RFA-AI-21-030)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
  
  

• Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed)
  (RFA-DK-20-026)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): September 23, 2021
  
  

• Kidney Precision Medicine Project Kidney Tissue Atlas Coordinating Center (U01 Clinical Trial Not Allowed)
  (RFA-DK-20-027)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): September 23, 2021
  
  

• Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)
  (RFA-DK-20-028)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): September 23, 2021
  
  

• Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)
  (RFA-DK-20-029)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): September 23, 2021
  
  

• Developmental Mechanisms of Human Structural Birth Defects (P01 Clinical Trial Not Allowed)
  (RFA-HD-22-004)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): July 29, 2021
  
  

• Pilot Effectiveness Trials of Interventions for Preschoolers with ADHD (R34 Clinical Trial Required)
  (RFA-MH-21-230)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed)
  (RFA-NS-21-012)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): December 15, 2021; April 15, 2022; December 15, 2022; April 14, 2023; December 15, 2023.